Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v2.4.0.6
Consolidated Statements of Cash Flows (Unaudited) (USD $)
 3 Months Ended
Feb. 28, 2013
Feb. 29, 2012
Cash flows from operating activities:    
Net income (loss) $ 244,006 $ (1,682,063)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization expense 104,786 110,204
Compensatory element of stock options 89,948 259,421
Provision for doubtful accounts 86,135 135,491
Equity in losses of affiliate 38,450 38,832
Loss on extinguishment of revenue sharing agreements   1,227,390
Changes in assets and liabilities:    
Accounts and notes receivable 102,292 (142,967)
Prepaid expenses and other current assets 108,604 (24,747)
Deposits and other assets, net 7,999 5,000
Accounts payable 234,994 402,304
Accrued expenses (320,401) 93,264
Deferred consulting obligation   (26,705)
Deferred revenue (191,138) (237,517)
Net cash provided by operating activities 505,675 157,907
Cash flows from investing activities:    
Restricted cash held in escrow 28,719  
Purchases of property and equipment (77,293) (79,241)
Proceeds from sale of marketable securities and other investments   1,002,000
Investments in patents (28,382) (12,177)
Net cash (used in) provided by investing activities (76,956) 910,582
Cash flows from financing activities:    
Long-term liability-revenue sharing agreements   (2,300,000)
Treasury stock purchases (247,045) (753,511)
Net cash used in financing activities (247,045) (3,053,511)
Increase (decrease) in cash and cash equivalents 181,674 (1,985,022)
Cash and cash equivalents - beginning of period 2,677,382 6,305,095
Cash and cash equivalents - end of period $ 2,859,056 $ 4,320,073